Research advances of dosing vericiguat in the treatment of heart failure in real world based upon clinical trial criteria
Vericiguat has been approved in the United States,Japan,European Union and China.It is indicated for heart fail-ure(HF)with reduced ejection fraction(＜45％).Here pharmaceutical characteristics and clinical trial results of vericiguat were summarized.This review focused upon the latest applications of vericiguat for HF based upon clinical trial criteria in real world.It provided references for proper managements of HR.
NETL
NSTL
万方数据
